Literature DB >> 24478500

Impact of changes in Clostridium difficile testing practices on stool rejection policies and C. difficile positivity rates across multiple laboratories in the United States.

Jessica Cohen1, Brandi Limbago, Ghinwa Dumyati, Stacy Holzbauer, Helen Johnston, Rebecca Perlmutter, John Dunn, Joelle Nadle, Carol Lyons, Erin Phipps, Zintars Beldavs, Leigh Ann Clark, Fernanda C Lessa.   

Abstract

We describe the adoption of nucleic acid amplification tests (NAAT) for Clostridium difficile diagnosis and their impact on stool rejection policies and C. difficile positivity rates. Of the laboratories with complete surveys, 51 (43%) reported using NAAT in 2011. Laboratories using NAAT had stricter rejection policies and increased positivity rates.

Entities:  

Mesh：

Year:  2013        PMID： 24478500      PMCID： PMC3911329          DOI： 10.1128/JCM.02177-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  16 in total

1.  Public reporting of Clostridium difficile and improvements in diagnostic tests.

Authors:  Simon D Goldenberg
Journal:  Infect Control Hosp Epidemiol       Date:  2011-12       Impact factor: 3.254

Review 2.  Detection, treatment, and prevention of Clostridium difficile infection.

Authors:  David L McCollum; J Martin Rodriguez
Journal:  Clin Gastroenterol Hepatol       Date:  2012-03-17       Impact factor: 11.382

Review 3.  Laboratory diagnosis of Clostridium difficile infection can molecular amplification methods move us out of uncertainty?

Authors:  Fred C Tenover; Ellen Jo Baron; Lance R Peterson; David H Persing
Journal:  J Mol Diagn       Date:  2011-08-18       Impact factor: 5.568

4.  Laboratory testing for Clostridium difficile infection: light at the end of the tunnel.

Authors:  Lance R Peterson; Maitry S Mehta; Parul A Patel; Donna M Hacek; Maureen Harazin; Payal P Nagwekar; Richard B Thomson; Ari Robicsek
Journal:  Am J Clin Pathol       Date:  2011-09       Impact factor: 2.493

5.  Is repeat PCR needed for diagnosis of Clostridium difficile infection?

Authors:  Robert F Luo; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2010-08-04       Impact factor: 5.948

6.  Vital signs: preventing Clostridium difficile infections.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-03-09       Impact factor: 17.586

Review 7.  Biology of Clostridium difficile: implications for epidemiology and diagnosis.

Authors:  Karen C Carroll; John G Bartlett
Journal:  Annu Rev Microbiol       Date:  2011       Impact factor: 15.500

8.  Clinical and laboratory characteristics of Clostridium difficile infection in patients with discordant diagnostic test results.

Authors:  Anna Kaltsas; Matt Simon; Larissa H Unruh; Crystal Son; Danielle Wroblewski; Kimberlee A Musser; Kent Sepkowitz; N Esther Babady; Mini Kamboj
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

9.  Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or enzyme immunoassay.

Authors:  Elisabeth Aichinger; Cathy D Schleck; William S Harmsen; Lisa M Nyre; Robin Patel
Journal:  J Clin Microbiol       Date:  2008-09-10       Impact factor: 5.948

10.  Laboratory diagnosis of Clostridium difficile infections: there is light at the end of the colon.

Authors:  Stephen M Brecher; Susan M Novak-Weekley; Elisabeth Nagy
Journal:  Clin Infect Dis       Date:  2013-06-20       Impact factor: 9.079
View more
  13 in total

1.  Clostridium difficile PCR Cycle Threshold Predicts Free Toxin.

Authors:  Fiona Senchyna; Rajiv L Gaur; Saurabh Gombar; Cynthia Y Truong; Lee F Schroeder; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2017-06-14       Impact factor: 5.948

Review 2.  Assessing the Burden of Clostridium difficile Infection in Low- and Middle-Income Countries.

Authors:  G A Roldan; A X Cui; N R Pollock
Journal:  J Clin Microbiol       Date:  2018-02-22       Impact factor: 5.948

3.  Use of antibiotic and prevalence of antibiotic-associated diarrhoea in-patients with spinal cord injuries: a UK national spinal injury centre experience.

Authors:  S Wong; P Santullo; J O'Driscoll; A Jamous; S P Hirani; M Saif
Journal:  Spinal Cord       Date:  2017-01-31       Impact factor: 2.772

4.  Molecular epidemiology of toxigenic Clostridioides difficile isolates from hospitalized patients and the hospital environment in Dhaka, Bangladesh.

Authors:  Amelia K Sofjan; Mohammad Aminul Islam; Kakali Halder; Nayel D Kabir; Ahmed Abu Saleh; Julie Miranda; Chris Lancaster; Khurshida Begum; M Jahangir Alam; Kevin W Garey
Journal:  Anaerobe       Date:  2019-07-26       Impact factor: 3.331

5.  Real-Time Electronic Tracking of Diarrheal Episodes and Laxative Therapy Enables Verification of Clostridium difficile Clinical Testing Criteria and Reduction of Clostridium difficile Infection Rates.

Authors:  Cynthia Y Truong; Saurabh Gombar; Richard Wilson; Gopalakrishnan Sundararajan; Natasa Tekic; Marisa Holubar; John Shepard; Alexandra Madison; Lucy Tompkins; Neil Shah; Stan Deresinski; Lee F Schroeder; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2017-03-01       Impact factor: 5.948

6.  Preventable Patient Harm: a Multidisciplinary, Bundled Approach to Reducing Clostridium difficile Infections While Using a Glutamate Dehydrogenase/Toxin Immunochromatographic Assay/Nucleic Acid Amplification Test Diagnostic Algorithm.

Authors:  Katherine Schultz; Emily Sickbert-Bennett; Ashley Marx; David J Weber; Lauren M DiBiase; Stacy Campbell-Bright; Lauren E Bode; Mike Baker; Tom Belhorn; Mark Buchanan; Sherie Goldbach; Jacci Harden; Emily Hoke; Beth Huenniger; Jonathan J Juliano; Michael Langston; Heather Ritchie; William A Rutala; Jason Smith; Shelley Summerlin-Long; Lisa Teal; Peter Gilligan
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

7.  Evaluating Epidemiology and Improving Surveillance of Infections Associated with Health Care, United States.

Authors:  Shelley S Magill; Ghinwa Dumyati; Susan M Ray; Scott K Fridkin
Journal:  Emerg Infect Dis       Date:  2015-09       Impact factor: 6.883

Review 8.  Infection prevention and control of Clostridium difficile: a global review of guidelines, strategies, and recommendations.

Authors:  Evelyn Balsells; Teodora Filipescu; Moe H Kyaw; Camilla Wiuff; Harry Campbell; Harish Nair
Journal:  J Glob Health       Date:  2016-12       Impact factor: 4.413

9.  Impact of a Healthcare Provider Educational Intervention on Frequency of Clostridium difficile Polymerase Chain Reaction Testing in Children: A Segmented Regression Analysis.

Authors:  Larry K Kociolek; Maria Bovee; Donna Carter; Jody D Ciolino; Rupal Patel; Anna O'Donnell; Angela H Rupp; Xiaotian Zheng; Stanford T Shulman; Sameer J Patel
Journal:  J Pediatric Infect Dis Soc       Date:  2017-06-01       Impact factor: 3.164

10.  Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection.

Authors:  Raymund Dantes; Yi Mu; Lauri A Hicks; Jessica Cohen; Wendy Bamberg; Zintars G Beldavs; Ghinwa Dumyati; Monica M Farley; Stacy Holzbauer; James Meek; Erin Phipps; Lucy Wilson; Lisa G Winston; L Clifford McDonald; Fernanda C Lessa
Journal:  Open Forum Infect Dis       Date:  2015-08-11       Impact factor: 3.835
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.